Advertisement
 
YOU ARE HERE: LAT HomeCollectionsSystemic Lupus Erythematosus
IN THE NEWS

Systemic Lupus Erythematosus

FEATURED ARTICLES
NEWS
October 28, 1985 | From Times Wire Services
About 7,000 Filipinos, vowing to avenge the police killing of two student protesters, marched Sunday on the palace of President Ferdinand E. Marcos, but riot troops blocked them several hundred yards away. "Blood for blood . . . that is a promise," the marchers chanted before setting fire to effigies of Marcos, President Reagan and Uncle Sam.
ARTICLES BY DATE
NEWS
March 29, 2011 | By Shari Roan, Los Angeles Times
Lupus nephritis can sometimes result in severe kidney disease,  a condition called end-stage renal disease. An alarming study published Monday found a significant increase in cases of this complication in people ages 5 through 39 and in African Americans. Lupus -- or systemic lupus erythematosus -- is an autoimmune disease that affects 300,000 Americans. It causes inflammation throughout the body as well as fatigue, joint pain and organ damage. Many patients eventually develop inflammation in the kidneys.
Advertisement
NEWS
March 29, 2011 | By Shari Roan, Los Angeles Times
Lupus nephritis can sometimes result in severe kidney disease,  a condition called end-stage renal disease. An alarming study published Monday found a significant increase in cases of this complication in people ages 5 through 39 and in African Americans. Lupus -- or systemic lupus erythematosus -- is an autoimmune disease that affects 300,000 Americans. It causes inflammation throughout the body as well as fatigue, joint pain and organ damage. Many patients eventually develop inflammation in the kidneys.
NEWS
November 17, 2010 | By Thomas H. Maugh II, Los Angeles Times
A Food and Drug Administration advisory panel Tuesday voted 13-2 to recommend approval of Benlysta, the first new drug to treat lupus in more than half a century.  The FDA has set Dec. 9 as the date to make a final decision on the drug. It doesn't have to follow the advice of its advisory panels, but it generally does. Benlysta is not a wonder drug that will provide relief to everybody with the debilitating disease, but it may provide benefits for some and allow them to taper off existing drugs, which have powerful side effects that some think are nearly as bad as the disease itself.
SPORTS
July 16, 1991 | MARYANN HUDSON
The Festival represents a new beginning for water polo player Eric Fischer of Chicago. Fischer was found in 1989 to have Systemic Lupus Erythematosus, or lupus. It is a chronic, inflammatory disease of unknown origin that can affect many organs. In Fischer's case, it attacked one of his kidneys and caused him to have a seizure that resulted in hospitalization. While there, he had five more seizures and suffered a minor stroke that erased part of his memory.
NEWS
November 17, 2010 | By Thomas H. Maugh II, Los Angeles Times
A Food and Drug Administration advisory panel Tuesday voted 13-2 to recommend approval of Benlysta, the first new drug to treat lupus in more than half a century.  The FDA has set Dec. 9 as the date to make a final decision on the drug. It doesn't have to follow the advice of its advisory panels, but it generally does. Benlysta is not a wonder drug that will provide relief to everybody with the debilitating disease, but it may provide benefits for some and allow them to taper off existing drugs, which have powerful side effects that some think are nearly as bad as the disease itself.
CALIFORNIA | LOCAL
October 8, 1985 | PATRICIA WARD BIEDERMAN, Times Staff Writer
An Argentine couple living in Canoga Park moved closer to their goal of saving the lives of their two sons Monday when Susana Gurtman, 47, donated her right kidney to son Eduardo, 23. Eduardo and his brother, Jorge, 22, suffer from lupus, a skin disease that can affect internal organs. According to their father, Dr. Angel Gurtman, who hopes to give one of his kidneys to Jorge, the transplant operations at UCLA Medical Center appeared, at least initially, to be successful.
CALIFORNIA | LOCAL
January 4, 1985 | BOB POOL, Times Staff Writer
The days pass slowly for Susana and Angel Gurtman. But they may be slipping by all too quickly for the Argentine couple's two sons. Eduardo and Jorge Gurtman have both suffered total kidney failure because of systemic lupus erythematosus, a skin disease that can also affect connective tissues and organs. Susana Gurtman is waiting to donate one of her kidneys to Eduardo, 22. Angel Gurtman is prepared to have one of his transplanted into Jorge, 21.
HEALTH
May 4, 1998 | WASHINGTON POST
Systemic lupus erythematosus, also known as lupus, is a difficult disease to diagnose because each patient displays a range of symptoms and no single test determines the condition. Common symptoms include extreme fatigue, painful or swollen joints, unexplained fever, skin rashes and kidney problems. Women--particularly black women--are much more likely than men to develop lupus, and the disease appears to run in families.
HEALTH
May 25, 1998
Many local senior centers offer activities, camaraderie and a special place to discuss senior concerns and issues. Churches and other places of worship often offer support or counseling services. The agencies listed below are among the many community resources for assistance with grief an bereavement. * Arthritis Foundation (800) 954-CURE Web site: http://www.arthritis.
SPORTS
July 16, 1991 | MARYANN HUDSON
The Festival represents a new beginning for water polo player Eric Fischer of Chicago. Fischer was found in 1989 to have Systemic Lupus Erythematosus, or lupus. It is a chronic, inflammatory disease of unknown origin that can affect many organs. In Fischer's case, it attacked one of his kidneys and caused him to have a seizure that resulted in hospitalization. While there, he had five more seizures and suffered a minor stroke that erased part of his memory.
NEWS
October 28, 1985 | From Times Wire Services
About 7,000 Filipinos, vowing to avenge the police killing of two student protesters, marched Sunday on the palace of President Ferdinand E. Marcos, but riot troops blocked them several hundred yards away. "Blood for blood . . . that is a promise," the marchers chanted before setting fire to effigies of Marcos, President Reagan and Uncle Sam.
CALIFORNIA | LOCAL
October 8, 1985 | PATRICIA WARD BIEDERMAN, Times Staff Writer
An Argentine couple living in Canoga Park moved closer to their goal of saving the lives of their two sons Monday when Susana Gurtman, 47, donated her right kidney to son Eduardo, 23. Eduardo and his brother, Jorge, 22, suffer from lupus, a skin disease that can affect internal organs. According to their father, Dr. Angel Gurtman, who hopes to give one of his kidneys to Jorge, the transplant operations at UCLA Medical Center appeared, at least initially, to be successful.
CALIFORNIA | LOCAL
January 4, 1985 | BOB POOL, Times Staff Writer
The days pass slowly for Susana and Angel Gurtman. But they may be slipping by all too quickly for the Argentine couple's two sons. Eduardo and Jorge Gurtman have both suffered total kidney failure because of systemic lupus erythematosus, a skin disease that can also affect connective tissues and organs. Susana Gurtman is waiting to donate one of her kidneys to Eduardo, 22. Angel Gurtman is prepared to have one of his transplanted into Jorge, 21.
NEWS
April 17, 2001 | Associated Press
CNN founder Ted Turner was suicidal after the breakup of his marriage to Jane Fonda and losing control of Turner Broadcasting in the reorganization of AOL Time Warner, according to the New Yorker. "I felt like Job," Turner said of his despondency last year. The magazine gave no details. In addition to his marital and business problems, Turner had smashed his foot in a skiing accident and was experiencing back problems.
BUSINESS
August 25, 2006 | From Reuters
GlaxoSmithKline said Thursday that it signed a drug discovery deal with California biotech firm ChemoCentryx Inc., potentially worth as much as $1.5 billion in milestone payments made upon achievement of certain goals and research funding to the privately owned company. Europe's biggest drug maker said Mountain View-based ChemoCentryx would also receive an upfront payment of $63.5 million, consisting of cash and an equity investment in the company.
Los Angeles Times Articles
|